XLS |
Net sales, operating result (EBIT) and research and development costs, by business sector (€ million)1 |
||||||||||||||||
|
|
|
|
|
||||||||||||
|
Healthcare |
Life Science |
Performance Materials |
Group2 |
||||||||||||
|
||||||||||||||||
|
|
|
|
|
||||||||||||
2014 |
|
|
|
|
||||||||||||
Net sales3 |
6,620.5 |
2,682.5 |
2,059.8 |
11,362.8 |
||||||||||||
Operating result (EBIT) |
1,106.4 |
289.2 |
611.5 |
1,762.0 |
||||||||||||
R&D costs |
1,366.0 |
162.6 |
170.6 |
1,703.7 |
||||||||||||
|
|
|
|
|
||||||||||||
20154 |
|
|
|
|
||||||||||||
Net sales3 |
6,933.8 |
3,355.3 |
2,555.6 |
12,844.7 |
||||||||||||
Operating result (EBIT) |
1,096.7 |
300.8 |
878.0 |
1,843.2 |
||||||||||||
R&D costs |
1,310.1 |
197.5 |
197.0 |
1,709.2 |